This clinical trial studies the omission of intact parathyroid hormone testing during surgery
in treating patients with primary hyperparathyroidism. Omission of intact parathyroid hormone
testing during parathyroid gland removal may help patients with primary hyperparathyroidism
to decrease their time under anesthesia, and decrease the overall time and cost of surgery.